Zheng, L
In the documented protocol, daily during the 4-week activation phase, then 5/week for weeks 58, then 23/week for maintenance
Similarly, tirzepatide can reach up to 15 mg per week in full-dose regimens, but microdosing typically begins around 1 to 2.5 mg
Combining GLP-1 Medications with Lifestyle Changes Pairing GLP-1 medications with diet and exercise has been shown to improve appetite control, enhance insulin function, and support habits that lead to lasting results
GLP-1 receptor activation inhibits glucagon secretion during normal and high blood sugar states, though critically not during hypoglycemia
[*] Negative Feedback Regulation: Sermorelin-induced growth hormone release is subject to negative feedback regulation involving somatostatin, a neurohormone that inhibits further hGH secretion